Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants

New England Journal of Medicine

Volumn 338, Issue 8, 1998, Pages 493-498

  Ballard, Roberta A ^a,i   Ballard, Philip L ^a   Cnaan, Avital ^a   Pinto Martin, Jennifer ^b   Davis, Deborah J ^c   Padbury, James F ^d   Phibbs, Roderic H ^e   Parer, Julian T ^e   Hart, Montgomery C ^f   Mannino, Frank L ^g   Sawai, Shirley K ^h  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PLACEBO; PROTIRELIN;

ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LUNG DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; RISK MANAGEMENT;

ADULT; CHRONIC DISEASE; DEXAMETHASONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LUNG DISEASES; MALE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PRENATAL CARE; RESPIRATORY DISTRESS SYNDROME, NEWBORN; THYROTROPIN-RELEASING HORMONE; TREATMENT OUTCOME;

EID: 6844255203     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199802193380802     Document Type: Article

References (31)

1. Zimmerman JJ, Farrell PM. Advances and issues in bronchopulmonary dysplasia. Curr Probl Pediatr 1994;24:159-70.
2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
3. Kari MA, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 1994;93:730-6.
4. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995;173:322-35.
5. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-62.
6. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:413-8.
7. Ballard PL, Hovey ML, Gonzales LK. Thyroid hormone Stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung. J Clin Invest 1984;74:898-905.
8. Thyroid hormones: effects and binding. In: Ballard PL. Hormones and lung maturation. Vol. 28 of Monographs on endocrinology. Berlin, Germany: Springer-Verlag, 1986:197-236.
9. Gross I, Dynia DW, Wilson CM, Ingleson LD, Gewolb IH, Rooney SA. Glucocorticoid-thyroid hormone interactions in fetal rat lung. Pediatr Res 1984;18:191-6.
10. Gonzales LW, Ballard PL, Ertsey R, Williams MC. Glucocorticoids and thyroid hormones stimulate biochemical and morphological differentiation of human fetal lung in organ culture. J Clin Endocrinol Metab 1986;62:678-91.
11. Schellenberg JC, Liggins GC, Manzai M, Kitterman JA, Lee CCH. Synergistic hormonal effects on lung maturation in fetal sheep. J Appl Physiol 1988;65:94-100.
12. Liggins GC, Schellenberg JC, Manzai M, Kitterman JA, Lee CCH. Synergism of cortisol and thyrotropin-releasing hormone on lung maturation in fetal sheep. J Appl Physiol 1988;65:1880-4.
13. Warburton D, Parton L, Buckley S, Cosico L, Enns G, Saluna T. Combined effects of corticosteroid, thyroid hormones, and β-agonist on surfactant, pulmonary mechanics, and β-receptor binding in fetal lamb lung. Pediatr Res 1988;24:166-70.
14. Boshier DP, Holloway H, Liggins GC, Marshall RJ. Morphometric analyses of the effects of thyrotropin releasing hormone and cortisol on the lungs of fetal sheep. J Dev Physiol 1989;12:49-54.
15. Ikegami M, Jobe AH, Pettenazzo A, Seidner SR, Berry DD, Ruffini L. Effects of maternal treatment with corticosteroids, T3, TRH, and their combinations on lung function of ventilated preterm rabbits with and without surfactant treatments. Am Rev Respir Dis 1987;136:892-8.
16. Ikegami M, Polk D, Tabor B, Lewis J, Yamada T, Jobe AH. Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function. J Appl Physiol 1991;70:2268-78.
17. Moya FR, Gross I. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences. Semin Perinatol 1993; 17:267-74.
18. Moya F, Mena P, Heusser F, et al. Response of the maternal, fetal, and neonatal pituitary-thyroid axis to thyrotropin-releasing hormone. Pediatr Res 1986;20:982-6.
19. Moya F, Mena P, Foradori A, Becerra M, Inzunza A, Germain A. Effect of maternal administration of thyrotropin releasing hormone on the preterm fetal pituitary-thyroid axis. J Pediatr 1991;119:966-71.
20. de Zegher F, Spitz B, Devlieger H. Prenatal treatment with thyrotropin releasing hormone to prevent neonatal respiratory distress. Arch Dis Child 1992;67:450-4.
21. Ballard PL, Ballard RA, Creasy RK, et al. Plasma thyroid hormones and prolactin in premature infants and their mothers after prenatal treatment with thyrotropin-releasing hormone. Pediatr Res 1992;32:673-8.
22. Morales WJ, O'Brien WF, Angel JL, Knuppel RA, Sawai S. Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. Obstet Gynecol 1989;73:111-6.
23. Ballard RA, Ballard PL, Creasy RK, et al. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. Lancet 1992;339:510-5.
24. Althabe F, Fustinana C, Althabe O, Ceriani Cernades JM. Controlled trial of prenatal betamethasone plus TRH vs. betamethasone plus placebo for prevention of RDS in preterm infants. Pediatr Res 1991;29:Suppl: 200A. abstract.
25. Knight DB, Liggins GC, Wealthall SR. A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Am J Obstet Gynecol 1994;171:11-6.
26. Crowther CA, Alfirevic Z. Antenatal thyrotropin-releasing hormone (TRH) prior to preterm delivery. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, eds. Pregnancy and childbirth module. Cochrane Database of Systematic Reviews, 1994. (Review no. 04749.)
27. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone (ACTOBAT) for prevention of neonatal respiratory disease. Lancet 1995;345:877-82.
28. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
29. Maturana A, Torres J, Salinas R, Moya F. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Am J Obstet Gynecol 1998;178:33-9.
30. Crowther CA, Hiller JE, Haslam RR, Robinson JS, ACTOBAT Study Group. Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. Pediatrics 1997;99:311-7.
31. McCormick M. The credibility of the ACTOBAT follow-up study. Pediatrics 1997;99:476-8.